Concepedia

Author

Takeshi Nakahara

Kyushu UniversityORCID

Also Known As

Hiroshi Uchi, Hiroyuki Murota, Nakahara Takeshi, T Nakahara, T. Nakahara, Takeshi NAKAHARA, Takeshi Nakahara, Tohru Nagano

355

Publications

7.3K

Citations

46

H-Index

108

Concepts

All Affiliations

Kyushu UniversityKyushu University HospitalKyoto Prefectural University of MedicineNagasaki UniversityThe University of Osaka
TN

About

Takeshi Nakahara is an author at Kyushu University specializing in medicine, dermatology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

39

1.6K

2

Public Health

2

2

37

3

Engineering

1

1

10

4

Health Sciences

1

1

10

5

Natural Sciences

1

1

10

Takeshi Nakahara

×

94

Publications

3.9K

Citations

37

H-Index

YearCitations

STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch

Miho Shiratori‐Hayashi, K. Koga, Hidetoshi Tozaki‐Saitoh,

Nature Medicine

2015

211

Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016

Hidehisa Saeki, Takeshi Nakahara, Akio Tanaka,

The Journal of Dermatology

2016

171

Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis

Gaku Tsuji, Akiko Hashimoto‐Hachiya, Mari Kiyomatsu‐Oda,

Cell Death and Disease

2017

135

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs

Takeshi Nakahara, Hiroshi Uchi, Alexander M. Lesokhin,

Blood

2010

134

Clinical practice guidelines for the management of atopic dermatitis 2018

Norito Katoh, Yukihiro Ohya, Masanori Ikeda,

The Journal of Dermatology

2019

127

The <scp>IL</scp>‐13/periostin/<scp>IL</scp>‐24 pathway causes epidermal barrier dysfunction in allergic skin inflammation

Yasutaka Mitamura, Satoshi Nunomura, Yasuhiro Nanri,

Allergy

2018

126

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Joanne R Chalmers, Eric L. Simpson, Christian Apfelbacher,

British Journal of Dermatology

2016

124

Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

Lisa A. Beck, Mette Deleuran, Robert Bissonnette,

American Journal of Clinical Dermatology

2022

96

Cynaropicrin attenuates UVB-induced oxidative stress via the AhR–Nrf2–Nqo1 pathway

Kenjiro Takei, Akiko Hashimoto‐Hachiya, Masakazu Takahara,

Toxicology Letters

2015

88

An ITAM-Syk-CARD9 signalling axis triggers contact hypersensitivity by stimulating IL-1 production in dendritic cells

Shinsuke Yasukawa, Yoshiyuki Miyazaki, Chika Yoshii,

Nature Communications

2014

85

Page 1